See more : Chengdu Olymvax Biopharmaceuticals Inc. (688319.SS) Income Statement Analysis – Financial Results
Complete financial analysis of Allmed Solutions Ltd (ALMD.TA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Allmed Solutions Ltd, a leading company in the Medical – Devices industry within the Healthcare sector.
- Henan Shenhuo Coal & Power Co.,Ltd (000933.SZ) Income Statement Analysis – Financial Results
- ITOCHU Techno-Solutions Corporation (ITTOY) Income Statement Analysis – Financial Results
- Youngbo Chemical Co., Ltd. (014440.KS) Income Statement Analysis – Financial Results
- CG Power and Industrial Solutions Limited (CGPOWER.BO) Income Statement Analysis – Financial Results
- Fine Semitech Corp. (036810.KQ) Income Statement Analysis – Financial Results
Allmed Solutions Ltd (ALMD.TA)
About Allmed Solutions Ltd
Allium Medical Solutions Ltd. develops, manufactures, and sells long-term, fully covered, expandable, and retrievable stents for the treatment of the various obstructions in the urinary and GI tract in Israel and internationally. The company offers ureteric, bulbar, triangular and round prostatic, and biliary stents. Allium Medical Solutions Ltd. is based in Caesarea, Israel.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 5.55M | 9.72M | 11.15M | 9.28M | 7.70M | 7.35M | 5.18M | 4.92M | 4.70M | 2.67M | 2.56M |
| Cost of Revenue | 0.00 | 0.00 | 2.46M | 4.35M | 6.92M | 6.10M | 5.69M | 5.17M | 4.42M | 5.70M | 15.36M | 5.09M | 3.33M |
| Gross Profit | 0.00 | 0.00 | 3.08M | 5.37M | 4.23M | 3.18M | 2.02M | 2.18M | 757.00K | -783.00K | -10.66M | -2.42M | -770.00K |
| Gross Profit Ratio | 0.00% | 0.00% | 55.60% | 55.26% | 37.95% | 34.27% | 26.17% | 29.67% | 14.62% | -15.93% | -226.65% | -90.56% | -30.04% |
| Research & Development | 6.64M | 359.00K | 59.00K | 6.92M | 12.21M | 273.00K | 343.00K | 224.00K | 147.00K | 213.00K | 16.38M | 540.00K | 6.02M |
| General & Administrative | 5.43M | 2.56M | 2.25M | 2.82M | 3.58M | 4.35M | 2.75M | 2.99M | 3.32M | 3.60M | 3.48M | 5.28M | 3.51M |
| Selling & Marketing | 0.00 | 0.00 | 236.00K | 1.55M | 2.82M | 1.23M | 1.04M | 1.08M | 1.07M | 1.36M | 1.45M | 1.81M | 1.25M |
| SG&A | 5.43M | 2.56M | 2.48M | 4.38M | 6.39M | 5.58M | 3.79M | 4.07M | 4.39M | 4.96M | 4.93M | 7.09M | 4.76M |
| Other Expenses | -8.73M | 9.38M | -5.70M | 2.00K | -36.45M | 196.00K | 41.00K | -300.00K | 14.69M | 16.85M | 6.31M | 18.32M | 3.58M |
| Operating Expenses | 3.34M | 12.30M | -3.16M | 11.30M | -17.85M | 26.11M | 24.86M | 24.82M | 19.22M | 22.02M | 27.62M | 25.95M | 14.36M |
| Cost & Expenses | 3.34M | 12.30M | -694.00K | 15.65M | -10.94M | 32.21M | 30.55M | 29.99M | 23.64M | 27.72M | 42.98M | 31.04M | 17.70M |
| Interest Income | 1.67K | 22.00K | 3.00K | 6.00K | 16.00K | 24.00K | 30.00K | 39.00K | 12.00K | 30.00K | 25.00K | 140.00K | 208.00K |
| Interest Expense | 0.00 | 46.00K | 96.00K | 207.00K | 248.00K | 75.00K | 75.00K | 67.00K | 63.00K | 61.00K | 61.00K | 54.00K | 62.00K |
| Depreciation & Amortization | 154.00K | 97.00K | 1.06M | 1.86M | 2.67M | 1.99M | 2.02M | 1.96M | 2.13M | 2.42M | 5.11M | 4.91M | 2.36M |
| EBITDA | -10.70M | -12.49M | -7.90M | -7.95M | 24.04M | -18.42M | -20.59M | -21.62M | -18.00M | -20.92M | -32.22M | -23.47M | -11.65M |
| EBITDA Ratio | 0.00% | 0.00% | 92.26% | -53.08% | 215.66% | -196.09% | -267.25% | -293.99% | -347.64% | -425.55% | -685.43% | -919.30% | -461.92% |
| Operating Income | -3.34M | -12.41M | 4.05M | -5.93M | 22.08M | -22.93M | -22.84M | -22.63M | -19.18M | -24.05M | -50.92M | -28.18M | -14.77M |
| Operating Income Ratio | 0.00% | 0.00% | 73.11% | -60.99% | 198.11% | -247.10% | -296.53% | -307.81% | -370.49% | -489.24% | -1,083.20% | -1,055.79% | -576.12% |
| Total Other Income/Expenses | 4.77M | 267.00K | -3.54M | -3.32M | 40.14M | 2.44M | 163.00K | -1.58M | -1.75M | -593.00K | 916.00K | -1.61M | 699.00K |
| Income Before Tax | 1.42M | -12.14M | 2.70M | -9.25M | 21.38M | -20.48M | -22.68M | -23.92M | -20.93M | -24.64M | -50.01M | -29.79M | -14.07M |
| Income Before Tax Ratio | 0.00% | 0.00% | 48.75% | -95.16% | 191.80% | -220.76% | -294.42% | -325.27% | -404.25% | -501.30% | -1,063.71% | -1,116.04% | -548.85% |
| Income Tax Expense | 0.00 | -947.00K | 1.25M | 1.64M | -621.00K | 2.52M | 240.00K | -945.00K | -948.00K | 714.00K | 13.59M | -1.26M | 572.00K |
| Net Income | 1.42M | -11.19M | 1.46M | -10.89M | 21.99M | -20.18M | -22.68M | -23.92M | -20.93M | -24.64M | -50.01M | -29.79M | -14.07M |
| Net Income Ratio | 0.00% | 0.00% | 26.28% | -112.08% | 197.25% | -217.43% | -294.42% | -325.27% | -404.25% | -501.30% | -1,063.71% | -1,116.04% | -548.85% |
| EPS | 12.71 | -129.08 | 18.73 | -119.65 | 309.34 | -264.53 | -339.43 | -450.92 | -526.90 | -1.34 | -5.05 | -3.50K | -2.97K |
| EPS Diluted | 12.71 | -127.41 | 18.73 | -119.65 | 309.34 | -264.53 | -339.43 | -450.92 | -526.90 | -1.34 | -5.05 | -3.50K | -2.97K |
| Weighted Avg Shares Out | 111.84K | 86.71K | 77.79K | 91.04K | 71.08K | 76.27K | 66.82K | 53.04K | 39.73K | 18.43M | 9.91M | 8.52K | 4.74K |
| Weighted Avg Shares Out (Dil) | 111.84K | 87.85K | 77.79K | 91.04K | 71.08K | 76.27K | 66.82K | 53.04K | 39.73K | 18.43M | 9.91M | 8.52K | 4.74K |
Source: https://incomestatements.info
Category: Stock Reports